Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Open accessThe DOI matches its Crossref record; 183 of the 187 references it cites were found in a registry or an index.
Abstract
New-onset diabetes after transplantation (NODAT) is associated with increased risk of allograft failure, cardiovascular disease and mortality, and therefore, jeopardizes the success of renal transplantation. Increased awareness of NODAT and the prediabetic states (impaired fasting glucose and impaired glucose tolerance, IGT) has fostered previous and present recommendations, based on the management of type 2 diabetes mellitus (T2DM). Unfortunately, the idea that NODAT merely resembles T2DM is potentially misleading, because the opportunity to initiate adequate anti-hyperglycaemic treatment early after transplantation might be given away for 'tailored' immunosuppression in patients who have developed NODAT or carry personal risk factors. Risk factor-independent mechanisms, however, seem to render postoperative hyperglycaemia with subsequent development of overt or 'full-blown' NODAT, the unavoidable consequence of the transplant and immunosuppressive process itself, at least in many cases. A proof of the concept that timely preventive intervention with exogenous insulin against post-transplant hyperglycaemia may decrease NODAT was recently provided by a small clinical trial, which is awaiting confirmation from a multicentre study. However, because early insulin therapy aimed at beta-cell protection seems to contrast the currently recommended, stepwise approach of 'watchful waiting' prior to pancreatic decompensation, we here aim at reviewing recent concepts regarding the development, prevention and treatment of NODAT, some of which seem to challenge the traditional view on T2DM and NODAT. In summary, we suggest a novel, risk factor-independent management approach to NODAT, which includes glycaemic monitoring and anti-hyperglycaemic treatment in virtually everybody after transplantation. This approach has widespread implications for future research and is intended to tackle NODAT and also ultimately cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The OGTT is considered the goldstandard test for the diagnosis of PTDM (1 year posttransplant) (138,139,148,149).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [139]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hyperglycemia is very common during the early posttransplant period, with 90% of kidney allograft recipients exhibiting hyperglycemia in the fi rst few weeks following transplant (138,139,141,142).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [139]
The cited source says what the claim attributes to it.
In the citing paper
“Hyperglycemia is very common during the early posttransplant period, with 90% of kidney allograft recipients exhibiting hyperglycemia in the first few weeks following transplant (138,139,141,142).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Lee, I.-M., Shiroma, E. J., Lobelo, F., Puska, P., Blair, S. N., & Katzmarzyk, P. T. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61031-9 · Cited by 8,215
Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,371
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., Willett, W. C., & Hu, F. B. (2010) · Diabetes Care · doi:10.2337/dc10-1079 · Cited by 2,116
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 1×
“These distinctions imply different physiological interpretations, although it may not be trivial to make inferences about treatment for T2DM, as a consequence of further untangling this puzzling relationship [131].”
BackgroundU.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., & Hu, F. B. (2010) · Circulation · doi:10.1161/circulationaha.109.876185 · Cited by 1,641
Immunosuppressive Drugs for Kidney Transplantation
Halloran, P. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra033540 · Cited by 1,555
Research works printed but not linked: 4
- 1984, American Journal of Physiology - Gastrointestinal and Liver Physiology, 247, E592
- 1992, American Journal of Physiology - Gastrointestinal and Liver Physiology, 263, E663
- Cerasi E. β-Cell dysfunction vs insulin resistance in type 2 diabetes: the eternal ‘chicken and egg’ question. Medicographia N° 106. 2011;33:35–41. [Google Scholar]
- Sharif A. Metformin safety post-transplantation—trials and tribulations. Am J Transplant. 2012;12:796. [Google Scholar]
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
“No studies to date have established which noninsulin agents are safest or most efficacious in PTDM.”
BackgroundMethodInfluential2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328
Factors influencing long-term outcome after kidney transplantation
Legendre, C., Canaud, G., & Martinez, F. (2014) · Transplant International · doi:10.1111/tri.12217 · Cited by 235
Autosomal dominant tubulointerstitial kidney disease
Devuyst, O., Olinger, E., Weber, S., Eckardt, K.-U., Kmoch, S., Rampoldi, L., & Bleyer, A. J. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0109-9 · Cited by 226
Metformin and other antidiabetic agents in renal failure patients
Lalau, J., Arnouts, P., Sharif, A., & Broe, M. E. D. (2014) · Kidney International · doi:10.1038/ki.2014.19 · Cited by 159
Schwaiger, E., Burghart, L., Signorini, L., Ristl, R., Kopecky, C., Tura, A., Pacini, G., Wrba, T., Antlanger, M., Schmaldienst, S., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15223 · Cited by 133
“Specifically, we aimed at determining the efficacy and safety of empagliflozin in KTRs by prospectively analyzing (1) insulin sensitiv‐ ity and secretion derived from an oral glucose tolerance test (OGTT) and daily glucose profiles; (2) side effects (infections, ketoacidosis, others).”
MethodSelf-citationManagement of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics
Hecking, M., Sharif, A., Eller, K., & Jenssen, T. G. (2020) · Transplant International · doi:10.1111/tri.13783 · Cited by 125
Haidinger, M., Werzowa, J., Hecking, M., Antlanger, M., Stemer, G., Pleiner, J., Kopecky, C., Kovarik, J. J., Döller, D., Pacini, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12518 · Cited by 110
Self-citationEmerging treatments for post-transplantation diabetes mellitus
Jenssen, T., & Hartmann, A. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.59 · Cited by 90
Strom Halden, T. A., Asberg, A., Vik, K., Hartmann, A., & Jenssen, T. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft536 · Cited by 89
Okorn, C., Goertz, A., Vester, U., Beck, B. B., Bergmann, C., Habbig, S., König, J. C., Konrad, M., Müller, D., Oh, J. S., et al. (2019) · Pediatric Nephrology · doi:10.1007/s00467-018-4188-8 · Cited by 72
Lv, C., Zhang, Y., Chen, X., Huang, X., Xue, M., Sun, Q., Wang, T., Liang, J., He, S., Gao, J., et al. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12275 · Cited by 69
Wissing, K. M., Abramowicz, D., Weekers, L. E., Budde, K., Rath, T., Witzke, O., Broeders, N., Kianda, M. N., & Kuypers, D. R. J. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14665 · Cited by 71
Post-Transplantation Diabetes Mellitus
Ahmed, S. H., Biddle, K., Augustine, T., & Azmi, S. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00790-5 · Cited by 77
Torres, A., Hernández, D., Moreso, F., Serón, D., Burgos, M. D., Pallardó, L., Kanter, J., Corte, C. D., Rodríguez, M., Díaz, J. M., et al. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.07.009 · Cited by 64
Kesiraju, S., Paritala, P., Ch, U. M. R., & Sahariah, S. (2013) · Transplant Immunology · doi:10.1016/j.trim.2013.10.006 · Cited by 68
Yates, C. J., Fourlanos, S., Colman, P. G., & Cohney, S. J. (2013) · Transplantation · doi:10.1097/tp.0b013e3182a012f3 · Cited by 60
Boerner, B. P., Miles, C. D., & Shivaswamy, V. (2014) · International Journal of Endocrinology · doi:10.1155/2014/617638 · Cited by 55
Vanhove, T., Remijsen, Q., Kuypers, D. R. J., & Gillard, P. (2016) · Transplantation Reviews · doi:10.1016/j.trre.2016.09.001 · Cited by 56
Immunosuppression and Post-transplant Hyperglycemia
Montero, N., & Pascual, J. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150331160846 · Cited by 54
Diabetes Care After Transplant
Wallia, A., Illuri, V., & Molitch, M. E. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.01.005 · Cited by 50
Prevalence and Predictors of Diabetes After Lung Transplantation: A Prospective, Longitudinal Study
Hackman, K. L., Snell, G. I., & Bach, L. A. (2014) · Diabetes Care · doi:10.2337/dc14-0663 · Cited by 49
Laecke, S. V., Nagler, E. V., Taes, Y., Biesen, W. V., Peeters, P. C., & Vanholder, R. C. (2014) · Transplant International · doi:10.1111/tri.12287 · Cited by 51
Lv, C., Chen, M., Xu, M., Xu, G., Zhang, Y., He, S., Xue, M., Gao, J., Yu, M., Gao, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099406 · Cited by 45
Lo, C., Jun, M., Badve, S. V., Pilmore, H., White, S. L., Hawley, C., Cass, A., Perkovic, V., & Zoungas, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009966.pub2 · Cited by 41
Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival
Eide, I. A., Halden, T. A. S., Hartmann, A., Dahle, D. O., Åsberg, A., & Jenssen, T. G. (2016) · Transplantation · doi:10.1097/tp.0000000000001259 · Cited by 46
Schwaiger, E., Krenn, S., Kurnikowski, A., Bergfeld, L., Pérez‐Sáez, M. J., Frey, A., Topitz, D., Bergmann, M. M., Hödlmoser, S., Bachmann, F., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021010127 · Cited by 43
Langsford, D., & Dwyer, K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i10.1132 · Cited by 44
Tacrolimus and sirolimus have distinct effects on insulin signaling in male and female rats
Shivaswamy, V., Bennett, R. G., Clure, C. C., Ottemann, B., Davis, J. S., Larsen, J. L., & Hamel, F. G. (2014) · Translational Research · doi:10.1016/j.trsl.2013.12.002 · Cited by 39
Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review
Cehic, M. G., Nundlall, N., Greenfield, J. R., & Macdonald, P. S. (2018) · Journal of Transplantation · doi:10.1155/2018/1025893 · Cited by 43
Sinangil, A., Çelik, V., Barlas, İ. S., Koç, Y., Baştürk, T., Şakacı, T., Akın, E. B., & Ecder, T. (2017) · Nefrología · doi:10.1016/j.nefro.2016.11.022 · Cited by 37
Hyperglycemia and Diabetes Mellitus Following Organ Transplantation
Galindo, R. J., & Wallia, A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0707-1 · Cited by 39
Lecronier, M., Tashk, P., Tamzali, Y., Tenaillon, O., Denamur, É., Barrou, B., Aron‐Wisnewsky, J., & Tourret, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227373 · Cited by 33
Benson, K. A., Maxwell, A. P., & McKnight, A. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147323 · Cited by 29
Berg, T., Aehling, N., Bruns, T., Welker, M., Weismüller, T. J., Trebicka, J., Tacke, F., Strnad, P., Sterneck, M. R., Settmacher, U., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2255-7246 · Cited by 32
Hyperglycemia management in patients with posttransplantation diabetes
Galindo, R. J., Fried, M., Breen, T., & Tamler, R. (2016) · Endocrine Practice · doi:10.4158/ep151039.ra · Cited by 25
Coemans, M., Loon, E. V., Lerut, E., Gillard, P., Sprangers, B., Senev, A., Emonds, M., Keer, J. M. V., Callemeyn, J., Daniëls, L., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1936 · Cited by 27
Cystic Fibrosis–related Diabetes: A First Canadian Clinical Practice Guideline
Coriati, A., Potter, K. J., Gilmour, J. A., Lam, G. Y., Nichols, C., Lands, L. C., Doyle, M.-A., Boudreau, V., Alexandre‐Heymann, L., McKinney, M. L., et al. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.09.001 · Cited by 28
Li, S., Zhou, H., Xie, M., Zhang, Z., Gou, J., Yang, J., Tian, C., Ma, K., Wang, C., Lü, Y., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15803 · Cited by 24
Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
Gupta, S., Pollack, T., Fulkerson, C., Schmidt, K., Oakes, D. J., Molitch, M. E., & Wallia, A. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00227 · Cited by 23
New-Onset Diabetes Mellitus after Kidney Transplantation
Alajous, S., & Budhiraja, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071928 · Cited by 24
García-Casarrubios, E., de Moura, C., Arroba, A. I., Pescador, N., Calderón‐Domínguez, M., Garcia, L., Herrero, L., Serra, D., Cadenas, S., Reis, F., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.016 · Cited by 21
Werzowa, J. M., Pacini, G., Hecking, M., Fidler, C., Haidinger, M., Brath, H., Thomas, A., Säemann, M. D., & Tura, A. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.014 · Cited by 20
Diabetes in Kidney Transplantation
Cantarin, M. P. M. (2021) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2021.10.004 · Cited by 19
Werzowa, J. M., Säemann, M. D., Mohl, A., Bergmann, M. M., Kaltenecker, C. C., Brozek, W., Thomas, A., Haidinger, M., Antlanger, M., Kovarik, J. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193569 · Cited by 17
Kurnikowski, A., Nordheim, E., Schwaiger, E., Krenn, S., Harreiter, J., Kautzky‐Willer, A., Leutner, M., Werzowa, J. M., Tura, A., Budde, K., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17187 · Cited by 16
Topitz, D., Schwaiger, E., Frommlet, F., Werzowa, J. M., & Hecking, M. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz244 · Cited by 16
Lopes, P. C. M. M., Fuhrmann, A., de Carvalho, F. J. N., Sereno, J., Santos, M. R., Pereira, M. J., Eriksson, J. W., Reis, F., & Carvalho, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.014 · Cited by 16
Post‐transplantation diabetes mellitus: evaluation of treatment strategies
Haidinger, M., Antlanger, M., Kopecky, C., Kovarik, J. J., Säemann, M. D., & Werzowa, J. M. (2015) · Clinical Transplantation · doi:10.1111/ctr.12541 · Cited by 17
Metformin Use and Long-term Clinical Outcomes in Kidney Transplant Recipients
Kwon, S., Kim, Y. C., Kwon, H., Cho, J., Kim, C., Son, H. E., Jeong, J.-C., Jung, I. M., Yoo, K. D., Kim, Y.-J., et al. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.01.446 · Cited by 16
Lo, C., Toyama, T., Oshima, M., Jun, M., Chin, K. L., Hawley, C. M., & Zoungas, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009966.pub3 · Cited by 30
The Role of TCF7L2 rs7903146 in Diabetes After Kidney Transplant
Quaglia, M., Terrazzino, S., Musetti, C., Cargnin, S., Merlotti, G., Cena, T., Stratta, P., & Genazzani, A. A. (2015) · Transplantation · doi:10.1097/tp.0000000000000978 · Cited by 13
van Wilpe, R., Hulst, A. H., Siegelaar, S. E., DeVries, J. H., Preckel, B., & Hermanides, J. (2022) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2022.111012 · Cited by 16
Antidiabetic therapy in post kidney transplantation diabetes mellitus
Werzowa, J. M., Säemann, M. D., Haidinger, M., Krebs, M., & Hecking, M. (2015) · Transplantation Reviews · doi:10.1016/j.trre.2015.01.001 · Cited by 14
Hyperparathyroidism and New Onset Diabetes After Renal Transplantation
Ivarsson, K. M., Clyne, N., Almquist, M., & Akaberi, S. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.07.076 · Cited by 13
Insuffisance rénale chronique et transplantation rénale
Thuret, R., Timsit, M., & Kleinclauss, F. (2016) · The French Journal of Urology · doi:10.1016/j.purol.2016.09.051 · Cited by 16
Dedinská, L., Baltesová, T., Beňa, Ľ., Čellár, M., Galajda, P., Chrastina, M., Jurčina, A., Kováčiková, L., Laca, Ľ., Lacková, E., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.09.041 · Cited by 11
Hecking, M., Sharif, A., Port, F. K., & Säemann, M. D. (2013) · Diabetes Care · doi:10.2337/dc13-1277 · Cited by 10
Alfieri, C., Molinari, P., Cinque, F., Vettoretti, S., Cespiati, A., Bignamini, D., Nardelli, L., Fracanzani, A. L., Castellano, G., & Lombardi, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147728 · Cited by 13
Renal posttransplantation diabetes mellitus: An overview
Pimentel, A. L., Bauer, A. C., & Camargo, J. L. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.010 · Cited by 13
Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study
Salah, D. M., Hafez, M. A. F., Fadel, F. I., Selem, Y. A. S., & Musa, N. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05669-0 · Cited by 8
Tacrolimus and Diabetes in Kidney Transplantation: The Impact of Cyp3a5 Gene Polymorphism
Liang, S., Zhu, X., Cai, R., Yan, B., Liang, W., Cai, M., & Yang, P. (2023) · Transplantation Proceedings · doi:10.1016/j.transproceed.2023.09.029 · Cited by 7
The relationship between periodontal status and hyperglycemia after kidney transplantation
Gomes, S. V., Rodrigues, V. P., Nunes-dos-Santos, D. L., Pereira, A. L. A., & Peres, M. A. (2021) · Clinical Oral Investigations · doi:10.1007/s00784-021-04011-6 · Cited by 7
Alkadi, M. M., Abuhelaiqa, E. A., Jerobin, J., Thappy, S., Khan, S., Abdelhalim, M. F., Asim, M., Fituri, O. M., Hamdi, A., Ashour, A., et al. (2020) · Clinical Transplantation · doi:10.1111/ctr.13892 · Cited by 7
Chaitou, A. R., Valmiki, S., Valmiki, M., Zahid, M., Aid, M., Fawzy, P., & Khan, S. (2022) · Cureus · doi:10.7759/cureus.23635 · Cited by 6
Skladaný, Ľ., Mesárošová, Z., Bachová, B., Stančík, M., & Dedinská, I. (2019) · Transplantation Proceedings · doi:10.1016/j.transproceed.2019.07.021 · Cited by 6
Complications of Pediatric Renal Transplantation
Dharnidharka, V. R., & Araya, C. E. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_67 · Cited by 6
Kipp, A., Marti, H., Bábíčková, J., Nakken, S., Leh, S. M., Halden, T. A. S., Jenssen, T. G., Vikse, B. E., Åsberg, A., Spagnoli, G. C., et al. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03294-z · Cited by 5
Perioperative Care for Kidney Transplant Recipients
Hultin, S., Hawley, C. M., Johnson, D. W., & Francis, R. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84388 · Cited by 6
Gentile, G., Somma, C., Gennarini, A., Mastroluca, D., Rota, G., Lacanna, F., Locatelli, B. G., Remuzzi, G., & Ruggenenti, P. L. (2015) · American Journal of Nephrology · doi:10.1159/000371728 · Cited by 5
Handisurya, A., Kerscher, C., Tura, A., Herkner, H., Payer, B. A., Mandorfer, M., Werzowa, J. M., Winnicki, W., Reiberger, T., Kautzky‐Willer, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145319 · Cited by 6
Iannino, N., Nasri, A., Räkel, A., Ducharme, A., Lachance, K., Racine, N., de Denus, S., Tremblay‐Gravel, M., Fortier, A., & White, M. (2018) · Journal of Transplantation · doi:10.1155/2018/9205083 · Cited by 5
Correspondence regarding the impact of kidney transplantation on insulin sensitivity
Bergfeld, L., Werzowa, J. M., Säemann, M. D., & Hecking, M. (2018) · Transplant International · doi:10.1111/tri.13124 · Cited by 5
New Onset Diabetes After Transplantation (NODAT) — scientific data review
Zielińska, K., Kukulski, L., Wróbel, M. P., Przybyłowski, P., Zielińska, M., & Strojek, K. (2020) · Clinical Diabetology · doi:10.5603/dk.2020.0047 · Cited by 6
Sinangil, A., Çelik, V., Barlas, İ. S., Koç, Y., Baştürk, T., Şakacı, T., Akın, E. B., & Ecder, T. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.02.008 · Cited by 4
Treating posttransplantation diabetes mellitus
Pérez‐Sáez, M. J., Marín-Casino, M., & Pascual, J. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1039983 · Cited by 3
Vinson, A. J., Thanamayooran, A., KIBERD, B. A., West, K. A., Siddiqi, F. S., Gunaratnam, L., & Tennankore, K. (2022) · Kidney360 · doi:10.34067/kid.0003742022 · Cited by 3
Analysis of Incretin Hormones After Orthotopic Liver Transplantation
Gámán, G., Sárváry, E., Gelley, F., Doros, A., Görög, D., Fehérvári, I., Kob́ori, L., Wagner, L. J., Máthé, Z., & Nemes, B. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.07.024 · Cited by 3
Langsford, D., Steinberg, A. G., & Dwyer, K. M. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0478-2 · Cited by 2
Association of COVID-19 With Risk of Posttransplant Diabetes Mellitus
Vinson, A. J., Anzalone, A. J., Schissel, M. E., Dai, R., Olex, A. L., Mannon, R. B., & Collaborative, O. B. O. T. N. C. C. (2024) · Transplantation · doi:10.1097/tp.0000000000005227 · Cited by 2
Tillmann, F.-P., Radtke, A., Rump, L. C., & Quack, I. (2017) · Experimental and Clinical Transplantation · doi:10.6002/ect.2016.0196 · Cited by 2
Management of new-onset diabetes post transplantation: calcineurin inhibitors and corticosteroids
Coleman, A., & Chai, M. O. (2014) · Journal of Renal Nursing · doi:10.12968/jorn.2014.6.5.234 · Cited by 1
Antidiabetic Medication in Patients with Chronic Kidney Disease: What's New?
Dominijanni, S., Cipriani, S., Malaguti, M., Triolo, L., Ansali, F., & Floccari, F. (2017) · Nephrology Point of Care · doi:10.5301/napoc.5000210 · Cited by 4
Diabetológia és szervátültetés
Wagner, L. J., Wittmann, I., Piros, L., Szabó, R. P., & Szakály, P. (2018) · Orvosi Hetilap · doi:10.1556/650.2018.31281 · Cited by 1
Patient and nursing experience of flash glucose monitoring following kidney transplantation
Shaban, A. A., Minas, K., Sunderland, A., Isard, T., Chan, D. T., Lim, W. H., & Chakera, A. (2023) · Nephrology · doi:10.1111/nep.14196 · Cited by 1
The causes of development and methods of correction of post-transplant diabetes mellitus
Lasareva, K. E., Николаевна, Р. О., & Zagorodnikova, N. V. (2017) · Transplantologiya The Russian Journal of Transplantation · doi:10.23873/2074-0506-2017-9-4-335-349 · Cited by 1
Diabetes in Kidney Transplant Recipients
Dhital, S. M. (2018) · Springer eBooks · doi:10.1007/978-3-030-00132-2_10 · Cited by 1
Post-liver transplantation diabetes mellitus — a clinical challenge for diabetologists?
Bhadada, S. K., & Pal, R. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-00955-3 · Cited by 1
Autosomal Dominant Tubulointerstitial Kidney Disease
Wolf, M. T. F., & Ariceta, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_120 · Cited by 1
Complicaciones quirúrgicas y su impacto en la supervivencia del injerto renal
Contreras, Y. M. (2015) · doi:10.35376/10324/16827
Metadata
- Authors
- Hecking, M., Werzowa, J., Haidinger, M., Horl, W. H., Pascual, J., Budde, K., Luan, F. L., Ojo, A., de Vries, A. P. J., Porrini, E., Pacini, G., Port, F. K., Sharif, A., Saemann, M. D., & European-New-Onset Diabetes After Transplantation Working Group
- Affiliations
- Medical University of Vienna (AT)
- Hospital Del Mar (ES)
- Charité – Universitätsmedizin Berlin (DE)
- University of Michigan (US)
- Universidad de La Laguna (ES)
- National Research Council (IT)
- Arbor Research Collaborative for Health (US)
- Queen Elizabeth Hospital Birmingham (GB)
- Corresponding author
- Hecking, M.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-17
- Volume
- 28
- Issue
- 3
- Pages
- 550-566
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- PMC
- PMC4375396
- OpenAlex
- W2164732183
- Cited by
- 120
- References
- 187
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 8 · 2023: 8 · 2022: 11 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 11 · 2017: 9 · 2016: 10 · 2015: 18 · 2014: 10 · 2013: 6
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK062234)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- post-transplant diabetes mellitus, kidney transplantation, type 2 diabetes, immunosuppression, impaired glucose tolerance, impaired fasting glucose, exogenous insulin therapy, beta-cell protection, glycaemic monitoring, allograft failure, cardiovascular disease
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Risk Factors, Organ Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.